Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05964023
Status:
RECRUITING
Last Update Posted:
2024-02-06
First Post:
2023-07-11
Brief Title:
pBFS Guided VS 5-cm Rule rTMS Over DLPFC for MDD
Sponsor:
Changping Laboratory
Organization:
Changping Laboratory
Study Overview
Official Title:
Personalized Brain Functional Sector-guided rTMS Therapy Targeting DLPFC VS 5-centimeter Rule for Major Depression
Status:
RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators aim to investigate whether the intervention effect of pBFS-guided rTMS therapy targeting DLPFC is superior to the intervention effect of the traditional 5 cm-rule guided rTMS therapy in patients with depressive disorders
Detailed Description:
After being informed about the study and potential risks All patients giving written informed consent will undergo a screening period to determine eligibility for study entry At week 0 patients who meet the eligibility requirements will be randomized in a blind manner in a 11 ratio to the pBFS group or 5-cm rule group Then all participants will undergo a 21-day rTMS modulation and 7-day 14-day and 45-day post-treatment follow-up visits Participants will not take any other treatment during the intervention and the 7-day and 14-day post-treatment visits
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None